この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
エネルギーと環境 · 2015/3/121 分で読めます
SHINE Medical Technologies, Inc.; Notice of Hearing, Opportunity To Intervene, Order Imposing Procedures
ローカル自動翻訳 · 情報源の原言語
概要
The U.S. Nuclear Regulatory Commission (NRC) has received a construction permit application from SHINE Medical Technologies, Inc. (SHINE), for approval of a proposed medical radioisotope production facility for the production of molybdenum-99 (Mo-99) at a site located in Janesville, Wisconsin. The NRC is currently conducting a detailed technical review of the construction permit application. If the construction permit application is approved, the applicant would be authorized to construct its proposed medical radioisotope production facility in accordance with the provisions of the construction permit.
情報源の原言語: Federal Register — Nuclear Regulatory Commission原文の発表を開く →